Rocket Pharmaceuticals Inc Shares Close the Week 20.5% Higher - Weekly Wrap
The company saw its shares close the week 20.5% higher than last week, with trading volume higher than its 30 day average.
Feb 11, 2022 by Kwhen Finance Editors
Rocket Pharmaceuticals Inc (RCKT) shares closed this week 20.5% higher than it did at the end of last week. The stock is currently down 11.5% year-to-date, down 68.2% over the past 12 months, and up 197.2% over the past five years. This week, the Dow Jones Industrial Average rose 0.4%, and the S&P 500 rose 0.6%.
Trading Activity
- Shares traded as high as $20.90 and as low as $15.75 this week.
- Trading volume this week was 59.7% higher than the 10-day average and 80.3% higher than the 30-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 1.7.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
- MACD, a trend-following momentum indicator, indicates an upward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
- The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and beats it on a 5-year basis
- The company's share price beats the Dow Jones Industrial Average this week, lags it on a 1-year basis, and beats it on a 5-year basis
- The company share price beats the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and beats it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Rocket Pharmaceuticals Inc | 1.5 | -11.5 | -68.2 | ||
| Dow Jones Industrial Average | -1.5 | -2.9 | 14.0 | -4.5 | 17.1 |
| S&P 500 Index | -2.0 | -5.4 | 16.7 | -6.4 | 22.4 |
| Health Care | -1.6 | -7.2 | 10.3 | -7.9 | 18.3 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by 9.0%
- The company's stock price performance over the past 12 months lags the peer average by 100.6%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Rocket Pharmaceuticals Inc | RCKT | 0 | -11.5 | -68.2 | ||
| Peer Avg | N/A | 0 | -10.6 | -34.0 | ||
| ORIC Pharmaceuticals Inc | ORIC | 0 | -39.3 | -73.7 | ||
| Otonomy Inc | OTIC | 0 | -2.9 | -62.2 | ||
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: